No Detail Found!

Comparison of Dexmedetomidine or Ondansetron with Haloperidol for Treatment of Postoperative Delirium in Trauma Patients Admitted to Intensive Care Unit: Randomized Controlled Trial.

Author(s)
Mohamed H Bakri Department of Anesthesia, Faculty of Medicine, Assiut University, Qesm Than Asyut, Assiut Governorate, (Egypt)
EmanA Ismail Department of Anesthesia, Faculty of Medicine, Assiut University, Qesm Than Asyut, Assiut Governorate, (Egypt)
Ahmed Ibrahim Department of Community Medicine, Faculty of Medicine, University of Western Kordofan, Al-Foula, South Kordofan, (Sudan)
Abstract
Objective: This study was designed to compare the effect of dexmedetomidine or ondansetron with haloperidol, as a control, for the treatment of postoperative delirium in trauma patients. Methodology: A total of 96 adult trauma patients diagnosed with postoperative delirium were randomized into three equal groups. Patients were given either 1 µg/kg dexmedetomidine (Dexmed group) or 4 mg ondansetron (Ondan group) or 5 mg haloperidol (Halo group), administered twice daily for 3 consecutive days. Number of delirious patients, patients who needed “rescue haloperidol” and the total amount of “rescue haloperidol” during study period was calculated. Results: At the end of the study, the number of remaining delirious patients was 3, 6, and 2 in Dexmed, Ondan, and Halo groups, respectively, without statistical significance. During the study period, there was no significant difference in the number of patients who needed “rescue haloperidol” between Dexmed and Halo groups (5 vs. 3; p = 0.7). However, the difference was significantly higher in Ondan group compared to Halo group (11 vs. 3; p = 0.03). The mean total “rescue haloperidol” dose was significantly higher in Ondan group compared to Halo group (p < 0.001), but there was no difference between Dexmed and Halo groups (p = 0.07). At the same time of delirium assessment, mean arterial blood pressure and mean score on Visual Analog Scale were not statistically different between Dexmed or Ondan group versus Halo group. No serious adverse events were reported. Conclusion: Dexmedetomidine is a potential alternative treatment for postoperative delirium in trauma patients admitted to ICU.
Publication Details
Page(s) 118-123
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 19, Issue: 2, Year: 2015

Request the full text from PASTIC

References
AmericanPsychiatric, 2006.Association practice guidelines for the treatment of psychiatric disorders:,Compendium 72 -73
LinSM,LiuCY,WangCH,LinHC,HuangCD,HuangPY, 2004.The impact of delirium on the survival of mechanically ventilated patients,Crit Care Med 32 2254 -9
ElyEW,ShintaniA,TrumanB,SperoffT,GordonSM,HarrellFE, 2004.Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit,JAMA 291 1753 -62
OuimetS,KavanaghBP,GottfriedSB,SkrobikY.,Incidence, 2007.risk factors and consequences of ICU delirium,Intensive Care Med 33 66 -73
PandharipandeP,CottonBA,ShintaniA,ThompsonJ,PunBT,MorrisJA, 2008.Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients,J Trauma 65 34 -41
BanhHL, 2012.Management of delirium in adult critically ill patients: an overview,J Pharm Pharm Sci 15 499 -509
MaldonadoJR,WysongA,van der StarrePJ,BlockT,MillerC,ReitzBA, 2009.Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery,Psychosomatics 50 206 -17
PandharipandePP,PunBT,HerrDL,MazeM,GirardTD,MillerRR, 2007.Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial,JAMA 298 2644 -53
ReadeMC,O'SullivanK,BatesS,GoldsmithD,AinslieWR,BellomoR, 2009.Dexmedetomidine vsehaloperidol in delirious, agitated, intubated patients: a randomised open-label trial,Crit Care 13 R75 -
RikerRR,ShehabiY,BokeschPM,CerasoD,WisemandleW,KouraF, 2009.Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial,JAMA 301 489 -99
GerlachAT,DastaJF, 2007.Dexmedetomidine: an updated review,Ann Pharmacother 41 245 -52
TagarakisGI,VoucharasC,TsolakiF,DaskalopoulosME,PapaliagkasV,ParisisC, 2012.Ondasetron versus haloperidol for the treatment of postcardiotomy delirium: a prospective, randomized, double-blinded study,J Cardiothorac Surg 21 25 -
PapadopoulosG,PouangareM,PapathanakosG,ArnaoutoglouE,PetrouA,TzimasP., 2014.The effect of ondansetron on postoperative delirium and cognitive function in aged orthopedic patients,Minerva Anestesiol 80 444 -51
BarrJ,FraserGL,PuntilloK,ElyEW,GélinasC,DastaJF, 2013.Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit,Crit Care Med 41 263 -306
ElyEW,InouyeSK,BernardGR,GordonS,FrancisJ,MayL, 2001.Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU),JAMA 286 2703 -10
BayindirO,AkpinarB,CanE,GüdenM,SönmezB,DemiroğluC., 2000.The use of the 5-HT3-receptor antagonist ondansetron for the treatment of postcardiotomy delirium,J Cardiothorac Vasc Anesth 14 288 -92
BergeronN,DuboisMJ,DumontM,DialS,SkrobikY.,Intensive Care Delirium Screening, 2001.Checklist: evaluation of a new screening tool,Intensive Care Med 27 859 -64
ShehabiY,GrantP,WolfendenH,HammondN,BassF,CampbellM, 2009.Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study),Anesthesiology 111 1075 -84
PasinL,LandoniG,NardelliP,BellettiA,Di PrimaAL,TaddeoD, 2014.Dexmedetomidine Reduces the Risk of Delirium, Agitation and Confusion in Critically Ill Patients: A Meta-analysis of Randomized Controlled Trials,J Cardiothorac Vasc Anesth 28 1459 -66
MaldonadoJR, 2008.Delirium in the acute care setting: characteristics, diagnosis and treatment,Crit Care Clin 24 657 -722
ZaalIJ,SlooterAJ, 2012.Delirium in critically ill patients: epidemiology, pathophysiology, diagnosis and management,Drugs 72 1457 -71
SandersR,MazeM., 2011.Contribution of sedative-hypnotic agents to delirium via modulation of the sleep pathway,Can J Anesth 58 149 -56
MoY,ZimmermannAE, 2013.Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients,Ann Pharmacother 47 869 -76
PandharipandeP,ShintaniA,PetersonJ,PunBT,WilkinsonGR,DittusRS, 2006.Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients,Anesthesiology 104 21 -6
CrawfordRD,BaskoffJD, 1980.Fentanylassociated delirium in man,Anesthesiology 53 168 -9
NelsonLE,LuJ,GuoT,SaperCB,FranksNP,MazeM., 2003.The alpha2- adrenoceptor agonist dexmedetomidine converges on an endogenous sleeppromoting pathway to exert its sedative effects,Anesthesiology 98 428 -36
VennRM,BradshawCJ,SpencerR,BrealeyD,CaudwellE,NaughtonC, 1999.Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit,Anaesthesia 54 1136 -42
0

Citations

0

Downloads

35

Views